MRI Mismatch-Based Intravenous Thrombolysis for Isolated Cerebellar Infarction

Stroke

Volumn 40, Issue 5, 2009, Pages 1897-1899

  Köhrmann, Martin ^a   Sauer, Roland ^a   Huttner, Hagen B ^a   Engelhorn, Tobias ^a   Doerfler, Arnd ^a   Schellinger, Peter D ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAMNESIS; ARTICLE; BRAIN PERFUSION; CASE REPORT; CEREBELLUM INFARCTION; CLINICAL FEATURE; DIFFUSION WEIGHTED IMAGING; EMERGENCY WARD; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; SUPERIOR CEREBELLAR ARTERY OCCLUSION; BRAIN ANGIOGRAPHY; BRAIN ARTERY; BRAIN CIRCULATION; BRAIN INFARCTION; CEREBELLUM; CEREBELLUM DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOLOGY; PERFUSION; PHYSIOLOGY; VASCULARIZATION;

FIBRINOLYTIC AGENT;

AGED; CEREBELLAR DISEASES; CEREBELLUM; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; PERFUSION;

EID: 65549121979     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.532838     Document Type: Article

References (9)

1. Jauss M, Krieger D, Hornig C, Schramm J, Busse O. Surgical and medical management of patients with massive cerebellar infarctions: Results of the German-Austrian cerebellar infarction study. J Neurol. 1999;246:257-264.
2. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-PA stroke study group. N Engl J Med. 1995;333:1581-1587.
3. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: A systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006;37:922-928.
4. Tohgi H, Takahashi S, Chiba K, Hirata Y. Cerebellar infarction. Clinical and neuroimaging analysis in 293 patients. The Tohoku cerebellar infarction study group. Stroke. 1993;24:1697-1701.
5. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
6. Schellinger PD, Thomalla G, Fiehler J, Kohrmann M, Molina CA, Neumann-Haefelin T, Ribo M, Singer OC, Zaro-Weber O, Sobesky J. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: An analysis of 1210 patients. Stroke. 2007;38:2640-2645.
7. Kohrmann M, Juttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, Ringleb PA, Schellinger PD, Hacke W. MRI versus CT-based thrombolysis treatment within and beyond the 3 htime window after stroke onset: A cohort study. Lancet Neurol. 2006;5:661-667.
8. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. The Desmoteplase in Acute Ischemic Stroke trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
9. Ostrem JL, Saver JL, Alger JR, Starkman S, Leary MC, Duckwiler G, Jahan R, Vespa P, Villablanca JP, Gobin YP, Vinuela F, Kidwell CS. Acute basilar artery occlusion: Diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke. 2004;35:e30-e34.